Article Details

Inflammatix Raises $102M in Series D Financing to Continue Development of Immune-Response ...

Retrieved on: 2021-03-16 11:26:23

Tags for this article:

Click the tags to see associated articles and topics

Inflammatix Raises $102M in Series D Financing to Continue Development of Immune-Response .... View article details on hiswai:

Excerpt

D1 Capital Partners led the round and current investors, including Northpond Ventures, Khosla Ventures, Think.Health, and OSF Healthcare Ventures, ...

Article found on: www.genomeweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo